According to the market research report released by Technavio, the global breast biopsy market is expected to accelerate at a CAGR of almost 11% during the forecast period. The growing incidence of breast cancer is one of the key factors triggering the growth of the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181025005795/en/
According to the market research report released by Technavio, the global breast biopsy market is expected to accelerate at a CAGR of almost 11% until 2021. (Graphic: Business Wire)
This research report titled 'Global Breast Biopsy Market 2017-2021' provides an in-depth analysis of the market in terms of revenue and emerging market trends. It also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
The market research analysis categorizes the global breast biopsy market into the following products:
- Needle-based biopsy systems
- Breast biopsy needles
- Biopsy imaging guidance systems
- Others such as tables, wires, forceps, sutures, and markers
The breast biopsy imaging guidance segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market segment's growth is the favorable sales of the high-priced guidance systems, the sales of new breast cancer biopsy imaging guidance systems, and the development of next-generation breast biopsy imaging guidance systems.
Global breast biopsy market: Top emerging trend
Increase in reimbursement of breast biopsy is an emerging trend in this market space. The rise in the number of breast biopsy procedures in the last few years has seen a corresponding increase in reimbursement of breast biopsies. Most of the medical healthcare facilities such as CMS had fixed payment for bundled breast biopsy devices in 2015. This has leveraged the reimbursement of hospitals by 51% compared with 2014 rates. This has brought a great opportunity for medical centers that are already providing stereotactic breast biopsy services.
Looking for more information on this market? Request a free sample report
Technavio's sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Technavio's report provides expert market research on the following topics:
Executive Report
- Market Outline
- Global Breast Biopsy Market Overview
Market Insights
- Market Sizing and Forecasts
- Market Growth
- Market Drivers and Challenges
- Key Emerging Trends
Market Segmentation Analysis
- Regional comparison (APAC, Americas, and EMEA)
- Key leading countries
- Market segmentation by product type (needle-based biopsy, breast biopsy needles, and biopsy imaging guidance systems)
- Market segmentation by modality (ultrasound, MRI, stereotactic X-ray, and without imaging biopsy)
- Market segmentation by end-user (hospitals, ASCs, and research centers)
Vendor Landscape
- Vendor classification
- Market positioning of vendors
- Competitive scenario
- Analysis of top vendors (BD, C.R. Bard, Hologic, and Leica Biosystems)
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181025005795/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com